0balateli
2018e thehiloe
Ka Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Ntlo-kholo251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
E thehiloe2018
BoemoE sebetsang
LipatentPatent e 1
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Litlhahlobo
Ha ho litlhahlobo hajoale. U sebelitse le Assertio Therapeutics, Inc.? Ba oa pele ho arolelana boiphihlelo ba hau.
Lintlha tsa molao
| Lebitso la molao | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Sheba ho GLEIF ↗ |
| Aterese e ngolisitsoeng | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Boemo | E sebetsang |
Mehloli: GLEIF · e ntlafalitsoe Oct. 16, 2026
Khokahano le lihokelo
Sebaka
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Na ena ke khampani ea hau?
Reka leqephe lena mahala ho eketsa logo, lihlahisoa, lifoto le mesebetsi, le ho araba litlhahlobo.
Reka leqephe lenaKena Heelky ho hokela, ho hira le ho hola
Theha ak'haonte ea mahala ho ngolla batho, ho kopa mesebetsi le ho phatlalatsa lithomo.
Kena hona joale — ke mahala